Technical / White Paper

Pharma Manufacturing: Attaining the Right Global Mix

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Curia, and any views and opinions expressed do not necessarily reflect those of

Pharma Manufacturing: Attaining the Right Global Mix

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links & re-igniting discussions around the value of reshoring production. The U.S. FDA reports 72% of facilities manufacturing APIs for American drugs are overseas, with 13% in China. Download our white paper where we discuss effective strategies to secure and de-risk pharmaceutical supply chains & reveal how AMRI assures the continual production of urgently needed drugs.

Related resources from Curia

Supplier info centre